文献速递胸部介入CT

经皮胸穿肺活检的诊断准确性:一项多中心研究

Diagnostic Accuracy of Percutaneous Transthoracic Needle Lung Biopsies: A Multicenter Study.
PubMed 文献 · Korean J Radiol · 2019-01-01

该多中心研究纳入2010年1月至2014年12月共9384例初次经皮胸穿肺活检,按意向诊断原则评估其诊断准确性。结果显示对恶性肿瘤诊断的总体准确率91.1%、敏感度92.5%、特异度86.5%,诊断失败率8.9%。病灶≤1 cm、亚实性病灶、仅用细针抽吸、最终诊断为良性病变或淋巴瘤为诊断失败的独立危险因素,锥形束CT和常规CT引导可降低诊断失败。

要点

  • 对恶性肿瘤诊断的准确率91.1%、敏感度92.5%、特异度86.5%,诊断失败率8.9%。
  • 仅用细针抽吸(AOR 2.43)和淋巴瘤最终诊断(AOR 10.66)是诊断失败的重要危险因素。
  • 锥形束CT(AOR 0.31)和常规CT引导(AOR 0.55)可降低诊断失败。

核心结论

  • 在该大型多中心队列中,经皮胸穿肺活检诊断恶性肿瘤的准确性相当高。
  • 识别出的诊断失败危险因素可能有助于减少诊断失败并解读活检结果。

研究设计与样本

  • 多中心研究,纳入2010年1月至2014年12月共9384例初次经皮胸穿肺活检,来自9239例患者(平均年龄65岁,范围20-99岁)。
  • 按意向诊断原则测量经皮胸穿肺活检诊断恶性肿瘤的准确性、敏感度、特异度、阳性预测值和阴性预测值,并分析诊断失败的危险因素。

诊断标准与关键数值

  • 诊断恶性肿瘤的总体准确率91.1%(95%CI 90.6-91.7%),敏感度92.5%(95%CI 91.9-93.1%),特异度86.5%(95%CI 85.0-87.9%),阳性预测值99.2%(95%CI 99.0-99.4%),阴性预测值84.3%(95%CI 82.7-85.8%)。
  • 诊断失败比例为8.9%(831/9384;95%CI 8.3-9.4%)。
  • 诊断失败的独立危险因素:病灶≤1 cm(AOR 1.86;95%CI 1.23-2.81)、病灶1.1-2 cm(AOR 1.75;95%CI 1.45-2.11)、亚实性病灶(AOR 1.81;95%CI 1.32-2.49)、仅用细针抽吸(AOR 2.43;95%CI 1.80-3.28)、最终诊断为良性病变(AOR 2.18;95%CI 1.84-2.58)、最终诊断为淋巴瘤(AOR 10.66;95%CI 6.21-18.30)。
  • 使用锥形束CT(AOR 0.31;95%CI 0.13-0.75)和常规CT引导(AOR 0.55;95%CI 0.32-0.94)可降低诊断失败。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To measure the diagnostic accuracy of percutaneous transthoracic needle lung biopsies (PTNBs) on the basis of the intention-to-diagnose principle and identify risk factors for diagnostic failure of PTNBs in a multi-institutional setting.

MATERIALS AND METHODS: A total of 9384 initial PTNBs performed in 9239 patients (mean patient age, 65 years [range, 20-99 years]) from January 2010 to December 2014 were included. The accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PTNBs for diagnosis of malignancy were measured. The proportion of diagnostic failures was measured, and their risk factors were identified.

RESULTS: The overall accuracy, sensitivity, specificity, PPV, and NPV were 91.1% (95% confidence interval [CI], 90.6-91.7%), 92.5% (95% CI, 91.9-93.1%), 86.5% (95% CI, 85.0-87.9%), 99.2% (95% CI, 99.0-99.4%), and 84.3% (95% CI, 82.7-85.8%), respectively. The proportion of diagnostic failures was 8.9% (831 of 9384; 95% CI, 8.3-9.4%). The independent risk factors for diagnostic failures were lesions ≤ 1 cm in size (adjusted odds ratio [AOR], 1.86; 95% CI, 1.23-2.81), lesion size 1.1-2 cm (1.75; 1.45-2.11), subsolid lesions (1.81; 1.32-2.49), use of fine needle aspiration only (2.43; 1.80-3.28), final diagnosis of benign lesions (2.18; 1.84-2.58), and final diagnosis of lymphomas (10.66; 6.21-18.30). Use of cone-beam CT (AOR, 0.31; 95% CI, 0.13-0.75) and conventional CT-guidance (0.55; 0.32-0.94) reduced diagnostic failures.

CONCLUSION: The accuracy of PTNB for diagnosis of malignancy was fairly high in our large-scale multi-institutional cohort. The identified risk factors for diagnostic failure may help reduce diagnostic failure and interpret the biopsy results.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee KH, Lim KY, Suh YJ, et al. Diagnostic Accuracy of Percutaneous Transthoracic Needle Lung Biopsies: A Multicenter Study. Korean J Radiol. 2019. PMID: 31339018. doi:10.3348/kjr.2019.0189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。